VALERIE VASQUEZ: Open Payments
NPI 1003528498 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$422 in 20 payments from 8 companies in 2025. Trend: 2023 $178 · 2024 $219 · 2025 $422
Food & beverage: $422
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $119 |
| Lilly USA, LLC | 5 | $95 |
| Amgen Inc. | 3 | $47 |
| Edwards Lifesciences Corporation | 1 | $45 |
| Exact Sciences Corporation | 2 | $41 |
| PFIZER INC. | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $18 |
Products named: Kerendia, JARDIANCE, MOUNJARO, OTEZLA, SAPIEN 3 Ultra RESILIA, The Cologuard Plus Collection Kit, PREVNAR 20, CAPVAXIVE.
Industry payments across TX — which companies pay providers there.
